ATS Stat

HomeATS Stat ▶ Stat October 16, 2019
Stat October 16, 2019

Time is Running Out to Submit Abstracts for ATS 2020!

The ATS is accepting submissions of scientific and case report abstracts on all aspects of respiratory disease, critical care, and sleep medicine. Abstracts can report on basic, translational, and clinical science research; epidemiologic, social, biobehavioral, and psychosocial investigations; or educational and quality improvement projects.

For information on submitting scientific abstracts and case reports, please contact the American Thoracic Society at

Submit now!

Deadline: 5 p.m. ET, Oct. 30, 2019


CDC Releases Clinical Guide on Vaping-Associated Lung Injury

The CDC has released new recommendations for the evaluation and treatment of patients with suspected vaping-associated lung injury. “Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping Product Use Associated Lung Injury – United States, October 2019” is the result of collaboration between the CDC and professional medical societies, including the American Thoracic Society.

Don Hayes, Jr., MD, and Carolyn Calfee, MD, represented the ATS on the expert panel that crafted the report.

The CDC recommends that people “consider refraining from using e-cigarette, or vaping, products that contain nicotine. Regardless of the ongoing investigation, e-cigarette, or vaping, products should never be used by youths, young adults, or women who are pregnant. Adults who do not currently use tobacco products should not start using e-cigarette, or vaping, products.”


Learn More About E-Cigarettes and Vaping

Please join ATS vaping experts for a Twitter chat about the vaping crisis. ATS experts Laura Crotty Alexander, MD, ATSF (@crottyalexander), Michelle Eakin, PhD (@mneakin), and Jon Samet, MD, MS (@Jon_Samet) will take questions and facilitate a discussion.

When: 4 p.m. ET, Oct. 30, 2019
Where: Twitter, using the hashtag #ATSChat

Learn more about the work the ATS is doing to combat vaping, and access resources for clinicians and patients, on the ATS website. More information is also available on the CDC website.



ATS/IDSA Publishes Clinical Guideline on Community Acquired Pneumonia

The American Thoracic Society and the Infectious Diseases Society of America have published an official clinical guideline on the diagnosis and treatment of adults with community acquired pneumonia (CAP) in the ATS’s Oct. 1 American Journal of Respiratory and Critical Care Medicine.

The guideline makes recommendations in response to key decisions facing clinicians caring for patients with CAP, including diagnostic testing, site of care, selection of initial empiric antibiotic therapy and subsequent disease management.

The latest guideline replaces one from 2007. Although some of the recommendations remain unchanged, the 2019 version revises recommendations for empiric treatment strategies and makes additional recommendations for disease management.

One important difference between the guidelines is that the 2019 version recommends more microscopic studies of respiratory tract samples in some subgroups of patients to avoid unnecessarily prescribing therapies for drug-resistant bacteria.

Read more now, and review the ATS Clinical Guideline Implementation tools.



Call for Papers: ATS Scholar

The ATS is pleased to announce the debut of ATS Scholar, their fourth journal, led by Nitin Seam, MD,  editor-in-chief. ATS Scholar is an online, open-access, education-themed journal, and we are soliciting original research articles, reviews, perspectives, videos, and other high-quality submissions in the following areas:

  • Career Development and Leadership Training
  • Communication Skills
  • Culture and Environment of Learning
  • Curricular Innovations
  • Education Technology
  • How to Teach Clinical Topics
  • Interprofessional Education
  • Patient Education
  • Procedural Training
  • Simulation
  • Quality Improvement and Implementation
  • Teaching Skills

Please submit manuscripts to:

Feel free to email Dr. Seam at with questions about potential submissions.